Literature DB >> 16679766

Polyunsaturated fatty acid supplementation stimulates differentiation of oligodendroglia cells.

M E van Meeteren1, W Baron, C Beermann, C D Dijkstra, E A F van Tol.   

Abstract

Dietary polyunsaturated fatty acids (PUFAs) have been postulated as alternative supportive treatment for multiple sclerosis, since they may promote myelin repair. We set out to study the effect of supplementation with n-3 and n-6 PUFAs on OLN-93 oligodendroglia and rat primary oligodendrocyte differentiation in vitro. It appeared that OLN-93 cells actively incorporate and metabolise the supplemented PUFAs in their cell membrane. The effect of PUFAs on OLN-93 differentiation was further assessed by morphological and Western blot evaluation of markers of oligodendroglia differentiation: 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), zonula occludens-1 (ZO-1) and myelin-associated glycoprotein (MAG). Supplementation of the OLN-93 cells with n-3 and n-6 PUFAs increased the degree of differentiation determined by morphological analysis. Moreover, CNP protein expression was significantly increased by gamma-linolenic acid (GLA, 18:3n-6) supplementation. In accordance with the OLN-93 results, studies with rat primary oligodendrocytes, a more advanced model of cell differentiation, showed GLA supplementation to promote oligodendrocyte differentiation. Following GLA supplementation, increased numbers of proteolipid protein (PLP)-positive oligodendrocytes and increased myelin sheet formation was observed during differentiation of primary oligodendrocytes. Moreover, increased CNP, and enhanced PLP and myelin basic protein expression were found after GLA administration. These studies provide support for the dietary supplementation of specific PUFAs to support oligodendrocyte differentiation and function. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679766     DOI: 10.1159/000091917

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  7 in total

Review 1.  Organotypic Cultures from the Adult CNS: A Novel Model to Study Demyelination and Remyelination Ex Vivo.

Authors:  Glaiza A Tan; Kendra L Furber; Merlin P Thangaraj; LaRhonda Sobchishin; J Ronald Doucette; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2017-08-09       Impact factor: 5.046

Review 2.  Docosahexaenoic acid and visual functioning in preterm infants: a review.

Authors:  Carly Molloy; Lex W Doyle; Maria Makrides; Peter J Anderson
Journal:  Neuropsychol Rev       Date:  2012-10-12       Impact factor: 7.444

Review 3.  The challenge of understanding cerebral white matter injury in the premature infant.

Authors:  C M Elitt; P A Rosenberg
Journal:  Neuroscience       Date:  2014-05-15       Impact factor: 3.590

4.  FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation.

Authors:  Kazem Sharifi; Yusuke Morihiro; Motoko Maekawa; Yuki Yasumoto; Hisae Hoshi; Yasuhiro Adachi; Tomoo Sawada; Nobuko Tokuda; Hisatake Kondo; Takeo Yoshikawa; Michiyasu Suzuki; Yuji Owada
Journal:  Histochem Cell Biol       Date:  2011-09-22       Impact factor: 4.304

5.  Erythropoietin Increases Myelination in Oligodendrocytes: Gene Expression Profiling Reveals Early Induction of Genes Involved in Lipid Transport and Metabolism.

Authors:  Georgina Gyetvai; Trisha Hughes; Florence Wedmore; Cieron Roe; Lamia Heikal; Pietro Ghezzi; Manuela Mengozzi
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

6.  Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination.

Authors:  Inge L Werkman; Janine Kövilein; Jenny C de Jonge; Wia Baron
Journal:  J Neurochem       Date:  2020-07-31       Impact factor: 5.372

7.  Transcriptional heterogeneity between primary adult grey and white matter astrocytes underlie differences in modulation of in vitro myelination.

Authors:  Inge L Werkman; Marissa L Dubbelaar; Pieter van der Vlies; Jelkje J de Boer-Bergsma; Bart J L Eggen; Wia Baron
Journal:  J Neuroinflammation       Date:  2020-12-11       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.